The phrase "analyses of the prognostic" is correct and usable in written English.
It can be used in contexts related to research, medical studies, or any field where predictions or forecasts are being evaluated or discussed.
Example: "The analyses of the prognostic factors revealed significant insights into patient outcomes."
Alternatives: "evaluations of the predictive" or "assessments of the forecasting".
Univariate and multivariate analyses of the prognostic features including pathological type, stage, and PORT were performed.
Univariate and multivariate analyses of the prognostic factors were examined by Cox's proportional hazard model.
However, straightforward comparative analyses of the prognostic factors among the WHO grade III gliomas have been reported infrequently.
The main assessment was by univariate and multivariate analyses of the prognostic value of PTEN status on death from prostate cancer.
There have been several analyses of the prognostic factors influencing overall survival in patients with primary STS (Collin et al, 1987; Gaynor et al, 1992; Pisters et al, 1996; Pisters and Pollock, 1999; Matsumoto et al, 2003).
This study reports univariate and multivariate analyses of the prognostic value of various pathological and staging factors based on 324 patients entered into the MRC randomised surgical trial for gastric cancer.
Meta-analysis of univariate analyses on the prognostic value of HER-2/neu showed that overexpression of HER-2/neu is associated with poor overall survival (HR: 1.67 (95% CI 1.34 2.08); Figure 5), but again considerable heterogeneity was present (I=59.6%).
Additionally, we performed a subgroup analysis for four studies reporting six analyses on the prognostic value of p53 in stage II I/IVtumours.
Secondly, our meta-analyses on the prognostic value of pre-treatment SUV measured on metastatic sites also showed that high SUV was an independent prognostic factor for poorer OS.
We used a large registry of patients awaiting coronary artery surgery 20 to estimate risk of events on the waiting list, and meta-analyses of the prognostic effect of biomarkers.
Therefore, it was not possible to analyse all of the prognostic factors in haematological malignancy patients, such as neutropaenia, or the type of HSCT received.
